AzTrials
AzTrials

Intermittent ExotropiaNCT04263103

A Training Software (SJ-RS-WL2015) Rehabilitating Intermittent Exotropia Binocular Functions

A study testing SJ-RS-WL2015 visual training program software in people with Intermittent Exotropia, run by Guangzhou Shijing Medical Software at 2 sites in China.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Evaluating the effect of SJ-RS-WL2015 visual training program in children with intermittent exotropia after eye surgery, including the improvement of simultaneous perception (I binocular function), fusion (II binocular function), stereopsis (III binocular function). Read more about this study

Who is it for?
Ages 5 to 16 years
Conditions the study is for
Intermittent Exotropia
What is being tested?
SJ-RS-WL2015 visual training program software
Could I receive a placebo?
No, everyone receives an active treatment
How many people
92 participants
Where
2 sitesChina
Study dates
9 Dec 2019to 31 Dec 2020
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 5 to 16 years
  • All sexes
  • No healthy volunteers
  • Child

Who may be able to join

  • Clinical diagnosis of Intermittent Exotropia
  • Must be after eye surgery for Intermittent Exotropia
  • Baseline Deviation Range: Esotropia<=5△ or Exotropia<15△ after Eye Surgery
  • Visual Acuity: >=20/20

Who cannot join

  • A-V patterns deviations
  • Abnormal oblique or vertical rectus
  • Nystagmus
  • Ophthalmoplegia
  • Anisometropia >2.5D
  • With other eye surgery history
Show all 16Show fewer
  • Mental disorder
  • Neural disease
  • Tumor
  • Heart disease
  • Hypertension
  • Epilepsy
  • Severe systemic disease
  • With vision therapy history within 4 weeks
  • Implanted electronic device
  • In other researches within 4 weeks

Trial locations and contacts

2 sites in 1 country.

China2 sites
  • Guangzhou Shijing Medical Software Co., Ltd.

    Guangzhou, Guangdong, 510000

  • Zhongshan Ophthalmic center, Sun Yat-sen University

    Guanzhou, Guangdong, 510000

Other trials in China

About this study

Official title: A Phase 4 Randomized, Single-blind Study to Evaluate the Multi-media Training(SJ-RS-WL2015)Software Rehabilitating Ability of Binocular Functions in Hospitalized Adolescent Patients With Intermittent Exotropia After Eye Surgery

Evaluating the effect of SJ-RS-WL2015 visual training program in children with intermittent exotropia after eye surgery, including the improvement of simultaneous perception (I binocular function), fusion (II binocular function), stereopsis (III binocular function).

Read the detailed description

All the patients are after eye surgery for intermittent exotropia. All the participants with 20/20 or better visual acuity.

Being tested
SJ-RS-WL2015 visual training program software
Keywords
Intermittent Exotropia

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • SJ-RS-WL2015 visual training program softwareOther

    Also called SJ-RS-WL2015 visual training program

    It is a software with perceptual learning methods for binocular functions

Study groups in NCT04263103
Study groupRoleWhat they receive
Experimental group with SJ-RS-WL2015ExperimentalItem code: SJ-RS-WL2015, a visual training software program, 15 minutes of one section, twice a day, and for 1 year
Receives: Other: SJ-RS-WL2015 visual training program software
control groupNo interventionNo special treatment, but observation

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change from Baseline Stereopsis at 12 months

    Measured with Synoptophore and Titmus stereo test, respectively

    Measured: 12 months

  2. Change from Baseline Fusion at 12 months

    Measured with Worth 4-dot test and Synoptophore, respectively

    Measured: 12 months

  3. Change from Baseline Simultaneous Perception at 12 months

    Measured with Bagolini striated lens, Worth 4-dot test, and Synoptophore, respectively

    Measured: 12 months

  4. Change from Baseline Stereopsis at 6 months

    Measured with Synoptophore and Titmus stereo test, respectively

    Measured: 6 months

  5. Change from Baseline Fusion at 6 months

    Measured with Worth 4-dot test and Synoptophore, respectively

    Measured: 6 months

  6. Change from Baseline Simultaneous Perception at 6 months

    Measured with Bagolini striated lens, Worth 4-dot test, and Synoptophore, respectively

    Measured: 6 months

  7. Change from Baseline Stereopsis at 3 months

    Measured with Synoptophore and Titmus stereo test, respectively

    Measured: 3 months

  8. Change from Baseline Fusion at 3 months

    Measured with Worth 4-dot test and Synoptophore, respectively

    Measured: 3 months

  9. Change from Baseline Simultaneous Perception at 3 months

    Measured with Bagolini striated lens, Worth 4-dot test, and Synoptophore, respectively

    Measured: 3 months

  10. Change from Baseline Stereopsis at 2 months

    Measured with Synoptophore and Titmus stereo test, respectively

    Measured: 2 months

  11. Change from Baseline Fusion at 2 months

    Measured with Worth 4-dot test and Synoptophore, respectively

    Measured: 2 months

  12. Change from Baseline Simultaneous Perception at 2 months

    Measured with Bagolini striated lens, Worth 4-dot test, and Synoptophore, respectively

    Measured: 2 months

  13. Change from Baseline Stereopsis at 1 month

    Measured with Synoptophore and Titmus stereo test, respectively

    Measured: 1 month

  14. Change from Baseline Fusion at 1 month

    Measured with Worth 4-dot test and Synoptophore, respectively

    Measured: 1 month

  15. Change from Baseline Simultaneous Perception at 1 month

    Measured with Bagolini striated lens, Worth 4-dot test, and Synoptophore,

    Measured: 1 month

Secondary outcomes (3)
  1. Visual Acuity

    by LogMAR Visual Acuity Chart

    Measured: one year

  2. Change from Baseline Deviation Degree at 1 year

    by Prism Test

    Measured: 1 year

  3. Change from Baseline Refractive Error at 1 year

    by Phoropter

    Measured: 1 year

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted10 Feb 2020
  2. Study start9 Dec 2019
  3. Primary completion31 Oct 2020 (estimated)
  4. Study completion31 Dec 2020 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Triple blind
Who is masked
Care provider, Investigator, Outcomes assessor
Enrolment
92 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04263103
Sponsor's protocol ID
GuangzhouShijingMS2020ITE
Status last verified
Feb 2020
First submitted
6 Feb 2020
Last updated
10 Feb 2020
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing SJ-RS-WL2015 visual training program software in people with Intermittent Exotropia, run by Guangzhou Shijing Medical Software at 2 sites in China.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 16 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 10 Feb 2020. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 2 sites in China. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change from Baseline Stereopsis at 12 months (time frame: 12 months). The study lists 15 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 10 Feb 2020.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in